AVITA Medical (RCEL) Return on Sales (2018 - 2025)

AVITA Medical's Return on Sales history runs 8 years deep, the most recent figure standing at 0.0% for Q4 2025.

• Quarterly Return on Sales rose 1.0% year-over-year to 0.0% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.0% (up 1.0% YoY) and the FY2025 annual result came in at 0.01%, changed 0.0% from the prior year.
• Return on Sales was 0.0% for Q4 2025 at AVITA Medical, up from 0.01% in the prior quarter.
• Across five years, Return on Sales topped out at 0.02% in Q4 2022 and bottomed at 0.02% in Q1 2024.
• A 5-year average of 0.01% and a median of 0.01% in 2021 frame the typical range for Return on Sales.
• Annual changes were most pronounced in 2021 — Return on Sales advanced 3 bps — and 2023, when it slipped 3 bps.
• AVITA Medical's Return on Sales stood at 0.01% in 2021, then surged by 455 bps to 0.02% in 2022, then slumped by 122 bps to 0.0% in 2023, then retreated by 29 bps to 0.01% in 2024, then jumped by 98 bps to 0.0% in 2025.
• Business Quant data shows RCEL's Return on Sales at 0.0% in Q4 2025, 0.01% in Q3 2025, and 0.01% in Q2 2025.